Alma Platinum IV Systematic Alpha R1C-ERegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 31/03/2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | -18,1 | 5,2 | 17,0 | 7,3 | 9,3 | |
+/-Cat | -18,0 | 2,7 | 9,8 | 9,8 | 2,1 | |
+/-Idx | -22,3 | -6,3 | 29,3 | -3,7 | 4,6 | |
Categorie: Alternative Systematic Futures EUR | ||||||
Benchmark: Morningstar EU Mod Gbl Tgt ... |
Kerngegevens | ||
Koers 24/04/2024 | EUR 14685,21 | |
Rendement 1 Dag | 0,69% | |
Morningstar Categorie™ | Alternative Systematic Futures EUR | |
ISIN | LU0462954800 | |
Grootte Fonds (Mil) 24/04/2024 | USD 119,72 | |
Grootte Fondsklasse (Mil) 24/04/2024 | EUR 9,63 | |
Aankoopkosten (Max) | 5,00% | |
Lopende Kosten Factor 15/02/2024 | 2,12% | |
Gesloten voor nieuwe beleggers | nee |
Morningstar Research |
Analyst Report | - , Morningstar, Inc |
After a dramatic 2020, Alma Platinum Systematic Alpha’s subadvisor Winton has found some stability, but outflows have continued, leaving this fund at a much-diminished size of USD 86 million at end-November 2021. Considering also our lack of... | |
Klik hier voor het analistenrapport |
Pijlers Morningstar | |
---|---|
Team | 23 |
Fondshuis | 23 |
Proces | 23 |
Rendement | |
Kosten |
Beleggingsdoelstelling: Alma Platinum IV Systematic Alpha R1C-E |
The investment objective of the Sub-Fund is to achieve long-term capital appreciation through compound growth by gaining exposure to global exchange-traded futures, forwards and options markets on commodities (including energies, base and precious metals and crops), equities and equity indices, bonds, short-term interest rates and currencies. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Simon Judes 15/06/2015 | ||
David Harding 15/06/2015 | ||
Oprichtingsdatum 14/07/2010 |
Advertentie |
Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
Not Benchmarked | Morningstar EU Mod Gbl Tgt Alloc NR EUR |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? Alma Platinum IV Systematic Alpha R1C-E | - |
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
|